Ross Davidson

3.0k total citations
56 papers, 2.0k citations indexed

About

Ross Davidson is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Ross Davidson has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 20 papers in Pharmacology and 19 papers in Infectious Diseases. Recurrent topics in Ross Davidson's work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Pneumonia and Respiratory Infections (18 papers) and Antibiotic Resistance in Bacteria (16 papers). Ross Davidson is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (19 papers), Pneumonia and Respiratory Infections (18 papers) and Antibiotic Resistance in Bacteria (16 papers). Ross Davidson collaborates with scholars based in Canada, United States and Sri Lanka. Ross Davidson's co-authors include Darrin J. Bast, Donald E. Low, Joyce C. S. de Azavedo, George G. Zhanel, Rodrigo B. Cavalcanti, James Brunton, Christine Fleming, Pamela Kibsey, James A. Karlowsky and Donald E. Low and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Ross Davidson

55 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Davidson Canada 25 1.1k 649 532 485 265 56 2.0k
María-José Giménez Spain 26 1.3k 1.2× 667 1.0× 539 1.0× 549 1.1× 265 1.0× 189 2.4k
Glenn A. Pankuch United States 28 1.5k 1.3× 1.1k 1.7× 898 1.7× 612 1.3× 274 1.0× 75 2.5k
Kimberly A. Nichol Canada 25 1.1k 1.0× 404 0.6× 713 1.3× 480 1.0× 254 1.0× 36 1.9k
Inga Odenholt Sweden 29 838 0.8× 729 1.1× 821 1.5× 673 1.4× 169 0.6× 73 2.4k
Yung-Ching Liu Taiwan 30 1.2k 1.1× 295 0.5× 521 1.0× 925 1.9× 360 1.4× 87 2.6k
Eugenio A. Debbia Italy 21 667 0.6× 312 0.5× 541 1.0× 577 1.2× 208 0.8× 94 1.6k
Michael L. Corrado United States 26 1.4k 1.3× 835 1.3× 526 1.0× 933 1.9× 227 0.9× 65 2.7k
Elena Loza Spain 23 783 0.7× 272 0.4× 507 1.0× 448 0.9× 263 1.0× 61 1.6k
Heike von Baum Germany 28 1.3k 1.2× 279 0.4× 486 0.9× 580 1.2× 175 0.7× 76 2.8k
Mariona Xercavins Spain 20 1.1k 1.0× 256 0.4× 809 1.5× 347 0.7× 201 0.8× 44 2.0k

Countries citing papers authored by Ross Davidson

Since Specialization
Citations

This map shows the geographic impact of Ross Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Davidson more than expected).

Fields of papers citing papers by Ross Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Davidson. The network helps show where Ross Davidson may publish in the future.

Co-authorship network of co-authors of Ross Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Davidson. A scholar is included among the top collaborators of Ross Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Davidson. Ross Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhanel, George G., Melanie Baxter, Philippe Lagacé‐Wiens, et al.. (2025). Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007–23). Journal of Antimicrobial Chemotherapy. 80(Supplement_2). ii15–ii26. 1 indexed citations
2.
Kyprianou, Miltiades, Keertan Dheda, A. Khattab, et al.. (2023). Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial aetiology. International Journal of Antimicrobial Agents. 62(4). 106942–106942. 6 indexed citations
3.
Lee, Song F., et al.. (2021). Carvacrol exhibits rapid bactericidal activity against Streptococcus pyogenes through cell membrane damage. Scientific Reports. 11(1). 1487–1487. 103 indexed citations
4.
5.
Adam, Heather J., Melanie Baxter, Ross Davidson, et al.. (2013). Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals. Journal of Antimicrobial Chemotherapy. 68(suppl 1). i31–i37. 42 indexed citations
6.
Tristram, SG, et al.. (2008). Characterization of extended-spectrum  -lactamase-producing isolates of Haemophilus parainfluenzae. Journal of Antimicrobial Chemotherapy. 61(3). 509–514. 29 indexed citations
7.
Davidson, Ross, Ian J. Davis, Barbara Willey, et al.. (2008). Antimalarial Therapy Selection for Quinolone Resistance among Escherichia coli in the Absence of Quinolone Exposure, in Tropical South America. PLoS ONE. 3(7). e2727–e2727. 23 indexed citations
8.
LeBlanc, Jason J., et al.. (2008). Uracil-DNA glycosylase (UNG) influences the melting temperature (Tm) of herpes simplex virus (HSV) hybridization probes. Journal of Virological Methods. 151(1). 158–160. 8 indexed citations
9.
Dylewski, Joe & Ross Davidson. (2006). Bacteremic pneumococcal pneumonia associated with macrolide failure. European Journal of Clinical Microbiology & Infectious Diseases. 25(1). 39–42. 5 indexed citations
10.
Melano, Roberto G., et al.. (2006). Cephalosporin resistance in Klebsiella pneumoniae from Nova Scotia, Canada. Diagnostic Microbiology and Infectious Disease. 56(2). 197–205. 13 indexed citations
11.
Davidson, Ross & Louis Péloquin. (2002). Anti-inflammatory Effects of the Macrolides. The Journal of Otolaryngology. 31(S1). S38–S38. 6 indexed citations
12.
Davidson, Ross, Rodrigo B. Cavalcanti, James Brunton, et al.. (2002). Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia. New England Journal of Medicine. 346(10). 747–750. 405 indexed citations
13.
14.
Weiss, Karl Heinz, C Restieri, Michél Laverdière, et al.. (2001). A Nosocomial Outbreak of Fluoroquinolone‐ResistantStreptococcus pneumoniae. Clinical Infectious Diseases. 33(4). 517–522. 93 indexed citations
15.
Davidson, Ross, et al.. (1998). A Cross‐Canada Surveillance of Antimicrobial Resistance in Respiratory Tract Pathogens. Canadian Journal of Infectious Diseases and Medical Microbiology. 10(2). 128–133. 17 indexed citations
16.
Davidson, Ross, et al.. (1994). The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect. Journal of Antimicrobial Chemotherapy. 34(3). 363–370. 4 indexed citations
17.
Zhanel, George G., Sung Ouk Kim, Ross Davidson, Daryl J. Hoban, & Lindsay E. Nicolle. (1993). Effect of Subinhibitory Concentrations of Ciprofloxacin and Gentamicin on the Adherence of <i>Pseudomonas aeruginosa</i> to Vero Cells and Voided Uroepithelial Cells. Chemotherapy. 39(2). 105–111. 10 indexed citations
18.
Hoban, D. J., et al.. (1992). In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies. Journal of Antimicrobial Chemotherapy. 30(suppl A). 59–65. 23 indexed citations
19.
20.
Zhanel, George G., James A. Karlowsky, Ross Davidson, & D. J. Hoban. (1991). Influence of Human Urine on the in vitro Activity and Postantibiotic Effect of Ciprofloxacin against <i>Escherichia coli</i>. Chemotherapy. 37(3). 218–223. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María-José Giménez Breakdown of academic impact, for papers by Glenn A. Pankuch Breakdown of academic impact, for papers by Kimberly A. Nichol Breakdown of academic impact, for papers by Inga Odenholt Breakdown of academic impact, for papers by Yung-Ching Liu Breakdown of academic impact, for papers by Eugenio A. Debbia Breakdown of academic impact, for papers by Michael L. Corrado Breakdown of academic impact, for papers by Elena Loza Breakdown of academic impact, for papers by Heike von Baum Breakdown of academic impact, for papers by Mariona Xercavins
Rankless by CCL
2026